Barinthus Biotherapeutics (BRNS) Capital Expenditures (QoQ) (2020 - 2025)
Barinthus Biotherapeutics (BRNS) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 540.00% |
| Mar 31, 2025 | -98.20% |
| Dec 31, 2024 | 143.86% |
| Sep 30, 2024 | -40.63% |
| Jun 30, 2024 | -37.66% |
| Mar 31, 2024 | 105.62% |
| Dec 31, 2023 | -208.28% |
| Sep 30, 2023 | 390.64% |
| Jun 30, 2023 | -177.48% |
| Mar 31, 2023 | 283.45% |
| Dec 31, 2022 | -84.71% |
| Sep 30, 2022 | 511.32% |
| Jun 30, 2022 | -42.58% |
| Mar 31, 2022 | 157.55% |
| Dec 31, 2021 | -40.45% |
| Sep 30, 2021 | 286.39% |
| Jun 30, 2021 | -197.45% |
| Mar 31, 2021 | 101.03% |
| Dec 31, 2020 | 113.93% |
| Sep 30, 2020 | -194.85% |